Baseline factors associated with treatment response in patients infected with hepatitis C virus 1b by stratification of IL28B polymorphisms
详细信息 查看全文
- 作者：Qihua Ling ; Jianjie Chen ; Hua Zhou ; Jun Zhong ; Yiyun Chen…
- 刊名：Archives of Virology
- 出版年：2015
- 出版时间：April 2015
- 年：2015
- 卷：160
- 期：4
- 页码：1105-1112
- 全文大小：203 KB
- 参考文献：1. Bibert, S, Roger, T, Calandra, T, Bochud, M, Cerny, A, Semmo, N (2013) IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction. J Exp Med 210: pp. 1109-1116 CrossRef
2. Bruno, S, Crosignani, A, Facciotto, C, Rossi, S, Roffi, L, Redaelli, A (2010) Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study. Hepatology 51: pp. 2069-2076 CrossRef
3. Derbala, M, Rizk, NM, Al-Kaabi, S, John, A, Sharma, M, El-Dweik, N (2013) The predictive value of IL-28B rs129860, rs11881222, and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients. Virology 444: pp. 292-300 CrossRef
4. Everhart, JE, Wright, EC (2013) Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV). Hepatology 57: pp. 1725-1733 CrossRef
5. Ferenci, P, Fried, MW, Shiffman, ML, Smith, CI, Marinos, G, Goncales, FL (2005) Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. J Hepatol 43: pp. 425-433 CrossRef
6. Fried, MW, Shiffman, ML, Reddy, KR, Smith, C, Marinos, G, Goncales, FL (2002) Peginterferon alfa-2a plus rivavirin for chronic hepatitis C virus infection. N Engl J Med 347: pp. 975-982 CrossRef
7. Garcia-Samaniego, J, Romero, M, Granados, R, Aleman, R, Juan, MJ, Suarez, D (2013) Factors associated with early virological response to peginterferon-alpha-2a/ribavirin in chronic hepatitis C. Wold J Gastroenterol 19: pp. 1943-1952
8. Ge, D, Felly, J, Thomapson, AJ, Simon, JS, Shianna, KV, Urban, TJ (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: pp. 399-401 CrossRef
9. Ghany, MG, Nelson, DR, Strader, DB, Thomas, DL, Seeff, LB (2011) An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 54: pp. 1433-1444 CrossRef
10. Ghany, MG, Strader, DB, Thomas, DL, Seeff, LB (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49: pp. 1335-1374 CrossRef
11. Guo, X, Zhao, Z, Xie, J, Cai, Q, Zhang, X, Peng, L (2012) Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype. Virol J 9: pp. 123 CrossRef
12. Hadziyannis, SJ, Sette, H, Morgen, TR, Balan, V, Diago, M, Marcellin, P (2004) Peginterferon-alfa2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140: pp. 346-355 CrossRef
13. Hanafiah, K, Groeger, J, Flaxman, AD, Wiersman, ST (2013) Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57: pp. 1333-1342 CrossRef
14. Jensen, DM, Morgan, TR, Marcellin, P, Pockros, PJ, Reddy, KR, Hadziyannis, SJ (2006) Early identification of HCV genotype 1 patients responding to 24?weeks peginterferon alpha-2a (40 KD)/ribavirin therapy. Hepatology 43: pp. 954-960 CrossRef
15. Lange, CM, Zeuzem, S (2011) IL28B single nucleotide polymorphisms in the treatment of hepatitis C. Hepatology 55: pp. 692-701
文摘
Although the single-nucleotide polymorphism (SNP) rs12979860 in the IL28B gene is a better predictor of sustained virological response to treatment of chronic hepatitis C (CHC) than other baseline factors, some CHC patients with the favorable C allele cannot achieve a sustained virological response when treated with peginterferon plus ribavirin. The aim of this study was to examine baseline factors as predictors of rapid virological response (RVR) and complete early virological response (cEVR) to peginterferon alfa-2a plus ribavirin treatment in Chinese CHC patients with hepatitis C virus (HCV) genotype 1b, with emphasis on the difference between the rs129860 CC and CT/TT genotypes. A total of 337 treatment-na?ve patients participated in this study. All patients were treated with peginterferon alfa-2a plus ribavirin at standard dosage. Serum samples from all patients were collected at baseline, week 4, and week 12 for testing of laboratory parameters, and IL28B genotypes were determined. Multivariate analysis showed that among rs12979860 CC genotype patients, glucose level and aspartate amino transferase (AST) activity were inversely associated with RVR, while abnormal platelet count and allergy inversely associated with cEVR. Among rs12979860 CT genotype patients, age below 40?years and short infection duration were associated with RVR, while age below 40?years, short infection duration, high body mass index (BMI), and no history of allergies were associated with cEVR. The baseline factors associated with the response to CHC treatment may depend on the IL28B genotype. Refinement of the baseline predictors based on IL28B genotypes may be useful for management of HCV infection.